Roflumilast Plus Montelukast in Adults With Severe Asthma
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of roflumilast 500 μg once daily (QD) plus montelukast 10
mg QD versus 10 mg montelukast QD alone on predose (trough) prebronchodilator forced
expiratory volume in the first second (FEV1).